Arcus Biosciences, Inc. (RCUS) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
3928 POINT EDEN WAY HAYWARD, CA 94545 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 978,000 | 759,000 | 1,009,000 | 499,308 | 173,415 | 57,937 | |||
| Cash and cash equivalent | 150,000 | 127,000 | 206,000 | 147,914 | 173,415 | 57,937 | |||
| Short-term investments | 828,000 | 632,000 | 803,000 | 351,394 | |||||
| Receivables | 5,000 | 4,000 | 4,000 | 2,227 | 1,592 | ||||
| Contract with customer, asset, after allowance for credit loss | 20,000 | 38,000 | 39,000 | 744,595 | 1,049 | 132 | |||
| Other undisclosed current assets | 13,000 | 30,000 | 15,000 | 15,620 | 559,759 | 134,636 | |||
| Total current assets: | 1,016,000 | 831,000 | 1,067,000 | 1,261,750 | 735,815 | 192,705 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 104,968 | 12,781 | |||||||
| Property, plant and equipment | 47,000 | 51,000 | 35,000 | 32,455 | 10,807 | 9,330 | |||
| Long-term investments and receivables | 14,000 | 107,000 | 129,000 | 181,990 | 6,440 | ||||
| Long-term investments | 14,000 | 107,000 | 129,000 | 181,990 | 6,440 | ||||
| Restricted cash and investments | 3,005 | 203 | 203 | ||||||
| Other noncurrent assets | 73,000 | 106,000 | 114,000 | 7,730 | 6,246 | 872 | |||
| Total noncurrent assets: | 134,000 | 264,000 | 278,000 | 330,148 | 36,477 | 10,405 | |||
| TOTAL ASSETS: | 1,150,000 | 1,095,000 | 1,345,000 | 1,591,898 | 772,292 | 203,110 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 18,000 | 17,000 | 20,000 | 52,905 | 33,857 | 14,226 | |||
| Taxes payable | ✕ | ✕ | ✕ | ✕ | 1,815 | ||||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 16,648 | 8,632 | |||
| Accounts payable | 18,000 | 17,000 | 20,000 | 10,261 | 15,682 | 4,704 | |||
| Accrued liabilities | 24,181 | 9,543 | 9,522 | ||||||
| Deferred revenue | 85,000 | 91,000 | 97,000 | 102,003 | 74,571 | 7,000 | |||
| Other liabilities | 123,000 | 76,000 | 76,000 | 52 | 3,566 | 1,480 | |||
| Other undisclosed current liabilities | 11,124 | 9,675 | |||||||
| Total current liabilities: | 226,000 | 184,000 | 193,000 | 166,084 | 121,669 | 22,706 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 116,887 | 15,243 | |||||||
| Liabilities, other than long-term debt | 391,000 | 449,000 | 495,000 | 467,477 | 133,076 | 16,562 | |||
| Deferred revenue | 234,000 | 307,000 | 355,000 | 462,217 | 122,830 | 12,022 | |||
| Deferred rent credit | 3,734 | ||||||||
| Other liabilities | 157,000 | 142,000 | 140,000 | 5,260 | 10,246 | 806 | |||
| Operating lease, liability | 116,887 | 15,243 | |||||||
| Total noncurrent liabilities: | 391,000 | 449,000 | 495,000 | 584,364 | 148,319 | 16,562 | |||
| Total liabilities: | 617,000 | 633,000 | 688,000 | 750,448 | 269,988 | 39,268 | |||
| Equity | |||||||||
| Equity, attributable to parent | 485,000 | 462,000 | 657,000 | 841,450 | 502,304 | 163,842 | |||
| Common stock | 1,617,000 | 1,311,000 | 1,206,000 | 7 | 6 | 4 | |||
| Additional paid in capital | 1,118,058 | 830,438 | 369,100 | ||||||
| Accumulated other comprehensive income (loss) | (7,000) | (1,261) | 44 | 64 | |||||
| Accumulated deficit | (1,132,000) | (849,000) | (542,000) | (275,354) | (328,184) | (205,326) | |||
| Total equity: | 485,000 | 462,000 | 657,000 | 841,450 | 502,304 | 163,842 | |||
| Other undisclosed liabilities and equity | 48,000 | ||||||||
| TOTAL LIABILITIES AND EQUITY: | 1,150,000 | 1,095,000 | 1,345,000 | 1,591,898 | 772,292 | 203,110 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 258,000 | 117,000 | 112,000 | 382,882 | 77,517 | 15,000 | ||
| Gross profit: | 258,000 | 117,000 | 112,000 | 382,882 | 77,517 | 15,000 | ||
| Operating expenses | (588,000) | (457,000) | (392,000) | (328,634) | (201,752) | (103,709) | ||
| Operating income (loss): | (330,000) | (340,000) | (280,000) | 54,248 | (124,235) | (88,709) | ||
| Nonoperating income | 48,000 | 39,000 | 14,000 | 397 | 1,377 | 3,999 | ||
| Interest and debt expense | (4,000) | |||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (286,000) | (301,000) | (266,000) | 54,645 | (122,858) | (84,710) | ||
| Loss from equity method investments | (613) | |||||||
| Other undisclosed income from continuing operations before income taxes | 4,000 | |||||||
| Income (loss) from continuing operations before income taxes: | (282,000) | (301,000) | (266,000) | 54,645 | (123,471) | (84,710) | ||
| Income tax expense | (1,000) | (6,000) | (1,000) | (1,815) | ||||
| Other undisclosed loss from continuing operations | ||||||||
| Income (loss) from continuing operations: | (283,000) | (307,000) | (267,000) | 52,830 | (123,471) | (84,710) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | 52,830 | (123,471) | (84,710) | |
| Other undisclosed net income | 613 | |||||||
| Net income (loss) available to common stockholders, diluted: | (283,000) | (307,000) | (267,000) | 52,830 | (122,858) | (84,710) | ||
Comprehensive Income ($ in thousands)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (283,000) | (307,000) | (267,000) | 52,830 | (122,858) | (84,710) | ||
| Other comprehensive income (loss) | 7,000 | (6,000) | (1,305) | (20) | 171 | |||
| Comprehensive income (loss): | (283,000) | (300,000) | (273,000) | 51,525 | (122,878) | (84,539) | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | ||||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (283,000) | (300,000) | (273,000) | 51,525 | (122,878) | (84,539) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.